RxDoctor Payments Data

Jeremy Petzold, PA

Physician Assistant · Saginaw, MINPI 1962090845

Payments from drug & device makers

$3,660in general payments, 2019–2025

Across 74 payments — averaging $49.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$2K
  • Astellas Pharma US Inc$402
  • Pfizer$203
  • Dendreon Pharmaceuticals LLC$164
  • AbbVie$151
  • Myovant Sciences Inc.$120
  • plus $848 from 18 others

What the payments were for

  • Travel & lodging$1,37638%
  • Food & beverage$1,75048%
  • Education$53415%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,660 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$55,085
Medicare patients
387
Services billed
743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide16$216,235
GemtesaVibegron83$61,956
MyrbetriqMirabegron79$59,522
Mirabegron ErMirabegron24$17,376
Tamsulosin Hcl419$9,019
Finasteride126$3,279
Testosterone29$2,893
Bicalutamide18$2,224
Silodosin29$1,823
Tadalafil18$1,704
Potassium Citrate ErPotassium Citrate12$1,658
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst33$1,509
Trospium Chloride25$1,470
Solifenacin Succinate36$1,438
Alfuzosin Hcl ErAlfuzosin Hcl15$572

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi, Myrbetriq$402$275,75795 claims
Sumitomo Pharma America, Inc.Gemtesa$51$61,95683 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →